|
8:00 |
8:30 |
9:00 |
9:30 |
10:00 |
10:30 |
11:00 |
11:30 |
12:00 |
12:30 |
13:00 |
13:30 |
14:00 |
14:30 |
15:00 |
15:30 |
16:00 |
16:30 |
17:00 |
17:30 |
18:00 |
| Mon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MEDM5231M01/LEC 14/1 |
Twelves,Christopher,Prof |
| Clinical Sciences LT (4.06) |
Lecture 14 - Early Phase Trials |
16 |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Clinical Sciences LT (4.06) |
Tutorial 3 - how to design trial for a given agent |
17 |
|
|
|
|
| Tue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Wed |
|
|
|
|
| Clinical Sciences SR (5.41) |
Tutorial 1, Group 2 -Journal club exercise on preclinical anti-cancer drug development |
14 |
|
|
|
|
|
| Clinical Sciences SR (5.41) |
Tutorial 2, Group 1 - Journal club exercise on clinical trial study |
14 |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| MEDM5231M01/ASST 1/1 |
Volpato,Milene,Dr, Klein,Ulf,Prof, Errington-Mais,Fiona,Dr, Bell,Sandra,Dr |
| Clinical Sciences SR (2.06), Clinical Sciences SR (5.41) |
Assessed Posters |
19 |
|
|
|
|
|
|
| |
|
|
|
|
| MEDM5231M01/LEC 01/1 |
Ingram,Nicola,Dr, Errington-Mais,Fiona,Dr |
| Clinical Sciences LT (4.06) |
Module Induction followed by Lecture 1 - Cancer Treatments |
C4 |
|
|
|
|
|
| MEDM5231M01/LEC 02/1 |
Laslo,Peter,Dr |
| Clinical Sciences LT (4.06) |
Lecture 2 Resistance to treatments |
C4 |
|
|
|
|
|
|
|
|
| |
|
|
|
| Clinical Sciences SR (2.06) |
Tutorial 1, Group 1 -Journal club exercise on preclinical anti-cancer drug development |
14 |
|
|
|
|
|
| MEDM5231M01/TUT 2/1 |
Samson,Adel,Dr |
| Clinical Sciences SR (2.06) |
Tutorial 2, Group 2 - Journal club exercise on clinical trial study |
14 |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| MEDM5231M01/LEC 04/1 |
Errington-Mais,Fiona,Dr |
| Clinical Sciences SR (2.06) |
Lecture 4 -Immunotherapies |
12 |
|
| MEDM5231M01/LEC 12/1 |
Smith,Sam,Prof |
| Clinical Sciences LT (4.06) |
Lecture 12 - Behavioural science and cancer prevention |
15 |
|
|
|
| MEDM5231M01/LEC 06/1 |
Vasudev,Naveen,Dr |
| Clinical Sciences SR (2.06) |
Lecture 6 - Target and biomarkers validation |
12 |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| MEDM5231M01/LEC 07/1 |
McLaughlan,James,Dr |
| Clinical Sciences LT (4.06) |
Lecture 7 - Nanoparticles |
13 |
|
| MEDM5231M01/LEC 05/1 |
Foster,Richard,Dr |
| Clinical Sciences SR (2.06) |
Lecture 5 - Medicinal chemistry for cancer therapy |
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| MEDM5231M01/LEC 15/1 |
Parrish,Chris,Dr |
| Clinical Sciences LT (4.06) |
Lecture 15 - Phase III/IV trials |
17 |
|
| MEDM5231M01/LEC 08/1 |
Burchill,Susan,Prof |
| Clinical Sciences LT (4.06) |
Lecture 8 - Preclinical models for drug development |
13 |
|
|
|
| MEDM5231M01/LEC 09/1 |
Volpato,Milene,Dr |
| Clinical Sciences SR (2.06) |
Lecture 9 - Drug repurposing |
13 |
|
|
|
| MEDM5231M01/LEC 03/1 |
Short,Susan,Prof |
| Clinical Sciences LT (4.06) |
Lecture 3 - Radiotherapy |
C4 |
|
|
|
|
|
|
| |
|
|
|
| MEDM5231M01/LEC 13/1 |
Mujica-Mota,Ruben,Dr |
| Clinical Sciences LT (4.06) |
Lecture 13 - Health Economics |
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| MEDM5231M01/TUT 4/1 |
Ingram,Nicola,Dr, Jennings,Victoria, McKimmie,Clive,Dr, Poulter,James,Dr |
| Clinical Sciences LT (4.06), Clinical Sciences SR (2.06), Clinical Sciences SR (5.41), Clinical Sciences SR (5.43) |
Tutorial 4 - Research study and poster design |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| MEDM5231M01/LEC 11/1 |
Hull,Mark,Prof |
| Clinical Sciences LT (4.06) |
Lecture 11 - Developing therapeutic approaches to cancer prevention |
15 |
|
| MEDM5231M01/LEC 10/1 |
Coletta,Louise,Dr |
| Clinical Sciences LT (4.06) |
Lecture 10 - Cancer drug pharmacology |
14 |
|
| MEDM5231M01/LEC 16/1 |
Gilbert,Alexandra |
| Clinical Sciences LT (4.06) |
Lecture 16 - Patient centered outcome research |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
| Thu |
|
|
|
|
| MEDM5231M01/ASST 2/1 |
Volpato,Milene,Dr, Errington-Mais,Fiona,Dr |
| Clinical Sciences SR (5.41) |
Assessed Posters |
19 |
|
|
|
|
|
|
|
|
|
|
|
|
| Fri |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sun |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|